IL-15 improves the effectiveness of GPC3 CAR T cells in targeting solid tumors
IL-15 enhances the growth and survival of GPC3 CAR T cells, improving their ability to target and fight solid tumors ...
Tag: Chimeric Antigen Receptor
Rice and MD Anderson collaborative harnesses engineering expertise for cancer solutions
Led by Rice's Gang Bao and MD Anderson's Dr. Jeffrey Molldrem, the initiative aims to foster collaboration between the two institutions ...
_on_a_T-cell_is_binding_to_a_molecule_on_a_cancer_-_Alpha_Tauri_3D_Graphics_M1_dc8762afeaee4937ad644739f274c7a5-620x480.jpg "Scientists aim to understand why T cells do not sustain energy in tumors")
Scientists aim to understand why T cells do not sustain energy in tumors
T cells are often called "assassins" or "killers" because they can orchestrate and carry out missions to hunt down bacteria, ...
Innovative CAR T cell therapy targets two proteins to combat aggressive brain tumor growth
In a recent report published in Nature Medicine, researchers presented the initial results of recurrent glioblastoma (rGBM) patients treated with ...
City of Hope cures oldest person of blood cancer and achieves HIV remission
City of Hope®, one of the largest cancer research and treatment organizations in the United States, treated the oldest person ...
CAR T cells target senescent cells, improve healthspan in mice
Chimeric antigen receptor (CAR) T cells have transformed the treatment of blood cancers in recent years. And there have been positive ...
St. Jude scientists discover potential CAR T cell therapy target for brain and solid tumors
Findings from St. Jude Children's Research Hospital are moving the field of cancer immunotherapy one step closer to treating brain ...
Phase III ZUMA-7 trial: Patients with high-risk large B-cell lymphoma lived longer with axi-cel
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric antigen ...
CAR T-cell therapy produces impressive results in first clinical trial in patients with multiple myeloma
A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced ...
Improving the immune defenses against blood cancer
For patients with lymphoma, multiple myeloma, or certain types of leukemia, treatment with chimeric antigen receptor T cells (CAR T ...
